356 related articles for article (PubMed ID: 33761344)
1. Human MC4R variants affect endocytosis, trafficking and dimerization revealing multiple cellular mechanisms involved in weight regulation.
Brouwers B; de Oliveira EM; Marti-Solano M; Monteiro FBF; Laurin SA; Keogh JM; Henning E; Bounds R; Daly CA; Houston S; Ayinampudi V; Wasiluk N; Clarke D; Plouffe B; Bouvier M; Babu MM; Farooqi IS; Mokrosiński J
Cell Rep; 2021 Mar; 34(12):108862. PubMed ID: 33761344
[TBL] [Abstract][Full Text] [Related]
2. Human Gain-of-Function MC4R Variants Show Signaling Bias and Protect against Obesity.
Lotta LA; Mokrosiński J; Mendes de Oliveira E; Li C; Sharp SJ; Luan J; Brouwers B; Ayinampudi V; Bowker N; Kerrison N; Kaimakis V; Hoult D; Stewart ID; Wheeler E; Day FR; Perry JRB; Langenberg C; Wareham NJ; Farooqi IS
Cell; 2019 Apr; 177(3):597-607.e9. PubMed ID: 31002796
[TBL] [Abstract][Full Text] [Related]
3. Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization.
Shinyama H; Masuzaki H; Fang H; Flier JS
Endocrinology; 2003 Apr; 144(4):1301-14. PubMed ID: 12639913
[TBL] [Abstract][Full Text] [Related]
4. Constitutive cholesterol-dependent endocytosis of melanocortin-4 receptor (MC4R) is essential to maintain receptor responsiveness to α-melanocyte-stimulating hormone (α-MSH).
McDaniel FK; Molden BM; Mohammad S; Baldini G; McPike L; Narducci P; Granell S; Baldini G
J Biol Chem; 2012 Jun; 287(26):21873-90. PubMed ID: 22544740
[TBL] [Abstract][Full Text] [Related]
5. Activation of MAPK by inverse agonists in six naturally occurring constitutively active mutant human melanocortin-4 receptors.
Mo XL; Tao YX
Biochim Biophys Acta; 2013 Dec; 1832(12):1939-48. PubMed ID: 23791567
[TBL] [Abstract][Full Text] [Related]
6. Differential Signaling Profiles of MC4R Mutations with Three Different Ligands.
Paisdzior S; Dimitriou IM; Schöpe PC; Annibale P; Scheerer P; Krude H; Lohse MJ; Biebermann H; Kühnen P
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059383
[TBL] [Abstract][Full Text] [Related]
7. The natural inverse agonist agouti-related protein induces arrestin-mediated endocytosis of melanocortin-3 and -4 receptors.
Breit A; Wolff K; Kalwa H; Jarry H; Büch T; Gudermann T
J Biol Chem; 2006 Dec; 281(49):37447-56. PubMed ID: 17041250
[TBL] [Abstract][Full Text] [Related]
8. Obesity-associated mutant melanocortin-4 receptors with normal Gα
Gillyard T; Fowler K; Williams SY; Cone RD
J Neuroendocrinol; 2019 Oct; 31(10):e12795. PubMed ID: 31529534
[TBL] [Abstract][Full Text] [Related]
9. Rescue of defective MC4R cell-surface expression and signaling by a novel pharmacoperone Ipsen 17.
Wang XH; Wang HM; Zhao BL; Yu P; Fan ZC
J Mol Endocrinol; 2014 Aug; 53(1):17-29. PubMed ID: 24780838
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological chaperones restore function to MC4R mutants responsible for severe early-onset obesity.
René P; Le Gouill C; Pogozheva ID; Lee G; Mosberg HI; Farooqi IS; Valenzano KJ; Bouvier M
J Pharmacol Exp Ther; 2010 Dec; 335(3):520-32. PubMed ID: 20826565
[TBL] [Abstract][Full Text] [Related]
11. A Novel Loss of Function Melanocortin-4-Receptor Mutation (MC4R-F313Sfs*29) in Morbid Obesity.
Trevellin E; Granzotto M; Host C; Grisan F; De Stefani D; Grinzato A; Lefkimmiatis K; Pagano C; Rizzuto R; Vettor R
J Clin Endocrinol Metab; 2021 Mar; 106(3):736-749. PubMed ID: 33247923
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological chaperone action in humanized mouse models of MC4R-linked obesity.
René P; Lanfray D; Richard D; Bouvier M
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33434184
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of melanocortin-4 receptor dimerization by substitutions in intracellular loop 2.
Piechowski CL; Rediger A; Lagemann C; Mühlhaus J; Müller A; Pratzka J; Tarnow P; Grüters A; Krude H; Kleinau G; Biebermann H
J Mol Endocrinol; 2013; 51(1):109-18. PubMed ID: 23674133
[TBL] [Abstract][Full Text] [Related]
14. Hypothalamic C2-domain protein involved in MC4R trafficking and control of energy balance.
Gavini CK; Cook TM; Rademacher DJ; Mansuy-Aubert V
Metabolism; 2020 Jan; 102():153990. PubMed ID: 31666192
[TBL] [Abstract][Full Text] [Related]
15. Lipid stress inhibits endocytosis of melanocortin-4 receptor from modified clathrin-enriched sites and impairs receptor desensitization.
Cooney KA; Molden BM; Kowalczyk NS; Russell S; Baldini G
J Biol Chem; 2017 Oct; 292(43):17731-17745. PubMed ID: 28878020
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activity in melanocortin-4 receptor: biased signaling of inverse agonists.
Tao YX
Adv Pharmacol; 2014; 70():135-54. PubMed ID: 24931195
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of feline melanocortin 4 receptor and melanocortin 2 receptor accessory protein 2.
Habara M; Mori N; Okada Y; Kawasumi K; Nakao N; Tanaka Y; Arai T; Yamamoto I
Gen Comp Endocrinol; 2018 May; 261():31-39. PubMed ID: 29360464
[TBL] [Abstract][Full Text] [Related]
18. Structural Complexity and Plasticity of Signaling Regulation at the Melanocortin-4 Receptor.
Kleinau G; Heyder NA; Tao YX; Scheerer P
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785054
[TBL] [Abstract][Full Text] [Related]
19. Defect in MAPK signaling as a cause for monogenic obesity caused by inactivating mutations in the melanocortin-4 receptor gene.
He S; Tao YX
Int J Biol Sci; 2014; 10(10):1128-37. PubMed ID: 25332687
[TBL] [Abstract][Full Text] [Related]
20. A heterozygous mutation in the third transmembrane domain causes a dominant-negative effect on signalling capability of the MC4R.
Tarnow P; Rediger A; Brumm H; Ambrugger P; Rettenbacher E; Widhalm K; Hinney A; Kleinau G; Schaefer M; Hebebrand J; Krause G; Grüters A; Biebermann H
Obes Facts; 2008; 1(3):155-62. PubMed ID: 20054175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
